Ronald Davis
Neurology with Special Qualifications in Child Neurology · Winter Park, FLNPI 1396792024
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $98,927 of the $153,529 with a category attached, or 64.4%. 31 manufacturers reported payments, led by UCB, Inc. at 47.4% of the total. Reporting peaked in 2023 at $36,806 and has fallen 83.5% since, to $6,064 in 2025. Among neurology with special qualifications in child neurology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 394 payments — averaging $389.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$73K
- Livanova USA, Inc.$29K
- Eisai Inc.$24K
- Neurelis, Inc.$10K
- Jazz Pharmaceuticals Inc.$6K
- Biocodex, Inc.$5K
- plus $7K from 25 others
Across 262 payments — averaging $2751.44 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$244K
- Takeda Pharmaceuticals U.S.A., Inc.$167K
- Eisai Inc.$83K
- Eli Lilly$83K
- Zogenix Inc.$76K
- UCB SA$20K
- plus $47K from 10 others
What the payments were for
- Consulting fees$25,32116%
- Speaking & faculty fees$98,92764%
- Travel & lodging$19,43313%
- Food & beverage$9,8486%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 174 | $72,762 |
| Livanova USA, Inc. | 53 | $29,369 |
| Eisai Inc. | 57 | $23,703 |
| Neurelis, Inc. | 21 | $9,557 |
| Jazz Pharmaceuticals Inc. | 19 | $6,274 |
| Biocodex, Inc. | 4 | $4,521 |
| UCB Biosciences Inc. | 1 | $1,750 |
| Otter Pharmaceuticals, LLC | 2 | $1,366 |
| Zogenix Inc. | 1 | $1,000 |
| Greenwich Biosciences, Inc. | 5 | $801 |
| AbbVie(2 entities) | 2 | $452 |
| ZOLL Medical Corporation | 1 | $375 |
| Sunovion Pharmaceuticals Inc. | 7 | $338 |
| Amneal Pharmaceuticals LLC | 1 | $229 |
| Supernus Pharmaceuticals, Inc. | 9 | $203 |
| Acadia Pharmaceuticals Inc | 7 | $158 |
| Sumitomo Pharma America, Inc. | 7 | $147 |
| Ironshore Pharmaceuticals Inc. | 6 | $130 |
| Catalyst Pharmaceuticals, Inc. | 3 | $71 |
| Natus Medical Incorporated | 1 | $68 |
| SK Life Science, Inc. | 2 | $46 |
| Aucta Pharmaceuticals, Inc. | 2 | $34 |
| Azurity Pharmaceuticals, Inc. | 1 | $27 |
| Immedica Pharma US, Inc. | 1 | $25 |
| Noven Therapeutics, LLC | 1 | $25 |
| Collegium Pharmaceutical, Inc. | 1 | $22 |
| Shockwave Medical, Inc | 1 | $18 |
| Amgen | 1 | $16 |
| Tris Pharma Inc | 1 | $15 |
| ITF Therapeutics LLC | 1 | $15 |
| Biomarin Pharmaceutical Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Fintepla$71,247
- Fycompa$22,967
- VNS Therapy$19,445
- VALTOCO$9,327
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR$7,680
- Epidiolex$6,534
- DIACOMIT$4,450
- VNS - Sentiva$1,500
- SYMPAZAN$1,338
- APTIOM$243
How this compares
$153,529 in reported general payments places this provider in the 95th percentile of 137 neurology with special qualifications in child neurology providers in Florida.
See all neurology with special qualifications in child neurology providers in Florida →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EpidiolexCannabidiol (Cbd) | 14 | $77,372 |
| Lacosamide | 12 | $6,174 |
| Levetiracetam | 14 | $682 |
Paid to pharmacies, not to this prescriber.
Other neurology with special qualifications in child neurology in Winter Park
- Paul WinnerWest Palm Beach$624K
- Omer Abdul HamidOrlando$283K
- Natalie GillsonFort Myers$250K
- Trevor ResnickMiami$230K
- Migvis MonduyMiami$188K
- Elza VasconcellosMiami$170K
- Ian MillerMiami$104K
- Michael HammerSaint Petersburg$100K
- Matt LallasMiami$88K
- Jose FerreiraTampa$88K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.